| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.4M | -2.2% |
| Cost of Revenue | $10.9M | -19.4% |
| Gross Profit | $6.6M | +51.4% |
| R&D Expense | $1.1M | -33.7% |
| SG&A Expense | $18.0M | -35.3% |
| Operating Income | -$15.6M | +79.2% |
| Pre-tax Income | -$19.7M | +72.8% |
| Income Tax | $68K | +101.1% |
| Net Income | -$17.9M | +72.9% |
| EPS (Basic) | -$11.42 | -564.0% |
| EPS (Diluted) | -$11.42 | -564.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.8M | -45.1% |
| Accounts Receivable | $907K | -59.7% |
| Inventory | $4.5M | -46.6% |
| Current Assets | $13.9M | -46.9% |
| Total Assets | $31.2M | -40.0% |
| Current Liabilities | $5.8M | -38.4% |
| Long-term Debt | $1.2M | -20.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.5M | +60.4% |
| Capital Expenditures | $31K | -97.6% |
| Investing Cash Flow | $4.7M | +293.8% |
| Financing Cash Flow | $656K | -80.1% |
| Free Cash Flow | -$11.5M | +62.0% |
| Total Liabilities |
| $7.0M |
| -39.9% |
| Stockholders' Equity | $24.2M | -40.1% |